Kathleen Golebiewski
Advertisement
Articles by Kathleen Golebiewski
Advertisement
Latest Updated Articles
Duvelisib for Relapsed or Refractory CLL/SLLJanuary 22nd 2019
Advertisement
Advertisement
Trending on Drug Topics
1
Some Providers Prescribe Unapproved Retatrutide for Weight-Loss at Alarming Rate
2
FDA Approves Lebrikizumab for 8 Week Maintenance of Atopic Dermatitis
3
Negative Pressure Wound Therapy Shows Benefits in Diabetic Chronic Wound
4
Q&A: Interoperable AI, Rural Health Transformation Are Reshaping Pharmacy’s Future
5